- Home
- FRPH vs AUTL Comparison
FRPH vs AUTL Comparison
Compare FRPH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- AUTL
- Stock Information
- Founded
- FRPH 1986
- AUTL 2014
- Country
- FRPH United States
- AUTL United Kingdom
- Employees
- FRPH N/A
- AUTL N/A
- Industry
- FRPH Real Estate
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRPH Finance
- AUTL Health Care
- Exchange
- FRPH Nasdaq
- AUTL Nasdaq
- Market Cap
- FRPH 491.1M
- AUTL 625.4M
- IPO Year
- FRPH N/A
- AUTL 2018
- Fundamental
- Price
- FRPH $25.25
- AUTL $1.38
- Analyst Decision
- FRPH
- AUTL Strong Buy
- Analyst Count
- FRPH 0
- AUTL 5
- Target Price
- FRPH N/A
- AUTL $9.12
- AVG Volume (30 Days)
- FRPH 38.7K
- AUTL 4.6M
- Earning Date
- FRPH 11-05-2025
- AUTL 11-11-2025
- Dividend Yield
- FRPH N/A
- AUTL N/A
- EPS Growth
- FRPH N/A
- AUTL N/A
- EPS
- FRPH 0.28
- AUTL N/A
- Revenue
- FRPH $32,293,999.00
- AUTL $29,934,000.00
- Revenue This Year
- FRPH N/A
- AUTL $634.25
- Revenue Next Year
- FRPH N/A
- AUTL $93.16
- P/E Ratio
- FRPH $90.19
- AUTL N/A
- Revenue Growth
- FRPH 3.18
- AUTL 185.17
- 52 Week Low
- FRPH $24.72
- AUTL $1.11
- 52 Week High
- FRPH $33.00
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- FRPH 43.51
- AUTL 28.28
- Support Level
- FRPH $24.96
- AUTL $1.34
- Resistance Level
- FRPH $25.77
- AUTL $1.46
- Average True Range (ATR)
- FRPH 0.50
- AUTL 0.10
- MACD
- FRPH -0.00
- AUTL 0.01
- Stochastic Oscillator
- FRPH 21.32
- AUTL 11.11
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.